A recent GBH News report highlights an ongoing shortage of morphine in Massachusetts, creating challenges for pharmacies and hospice providers who rely on it to manage end-of-life pain. Pharmacists report weeks-long back orders for injectable and liquid morphine sulfate, leaving some assisted-living and home-hospice patients without their usual pre-filled syringes.

The shortage, linked to thin profit margins for generics and possible supply-chain disruptions, limits options for patients who cannot swallow tablets or need fast-acting liquid forms. Hospice leaders say the impact is “being managed,” but families are urged to contact their pharmacists and care teams early to plan for medication needs.